XML 41 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Accounts (Tables)
3 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash, Cash Equivalents, Short-Term Investments and Marketable Securities
Summary of Cash and Available-for-Sale Securities (in thousands)
 
 
September 30, 2014
 
June 30, 2014
Cash
$
71,190

 
$
72,623

 
 
 
 
Cash equivalents
$
2,877

 
$
567

Short-term investments
30,395

 
32,692

Total available-for-sale
$
33,272

 
$
33,259

 
 
 
 
Total cash, cash equivalents and available for sale securities
$
104,462

 
$
105,882

Available-for-sale Securities
The following is a summary of available-for-sale securities (in thousands): 
 
Amortized
Cost
 
Fair Value
 
Unrealized
Holding
Gains
 
Unrealized
Holding
Losses
September 30, 2014
 
 
 
 
 
 
 
Money market funds
$
2,877

 
$
2,877

 
$

 
$

U.S. corporate debt securities
30,338

 
30,395

 
57

 

 
$
33,215

 
$
33,272

 
$
57

 
$

Classified as:
 
 
 
 
 
 
 
Cash equivalents
$
2,877

 
$
2,877

 
$

 
$

Short-term investments
30,338

 
30,395

 
57

 

 
$
33,215

 
$
33,272

 
$
57

 
$

June 30, 2014
 
 
 
 
 
 
 
Money market funds
$
567

 
$
567

 
$

 
$

U.S. corporate debt securities
32,578

 
32,692

 
114

 

 
$
33,145

 
$
33,259

 
$
114

 
$

Classified as:
 
 
 
 
 
 
 
Cash equivalents
$
567

 
$
567

 
$

 
$

Short-term investments
32,578

 
32,692

 
114

 

Marketable securities

 

 

 

 
$
33,145

 
$
33,259

 
$
114

 
$

 
The amortized cost and estimated fair value of available-for-sale investments in debt securities at September 30, 2014, by contractual maturity, were as follows (in thousands):
 
 
Amortized
Cost
 
Fair
Value
Due in 1 year or less
$
23,312

 
$
23,363

Due in 1-2 years
6,024

 
6,027

Due in 2-5 years
1,002

 
1,005

Total investments in available for sale debt securities
$
30,338

 
$
30,395

Schedule of Deferred Revenue, Net
The following table summarizes deferred revenue, net at September 30, 2014 and June 30, 2014, respectively (in thousands):
 
 
September 30, 2014
 
June 30, 2014
Deferred services
$
87,012

 
$
89,657

Deferred product and other revenue
7,555

 
8,020

Total deferred revenue
94,567

 
97,677

Less: current portion
72,599

 
74,735

Non-current deferred revenue, net
$
21,968

 
$
22,942

Change in Deferred Support Revenue
The change in the Company’s deferred support revenue balance in relation to these arrangements was as follows (in thousands):
 
 
Three Months Ended
 
September 30, 2014
 
September 30, 2013
Balance beginning of period
$
89,657

 
$
38,003

New support arrangements
28,539

 
13,343

Recognition of support revenue
(31,184
)
 
(14,255
)
Balance end of period
87,012

 
37,091

Less: current portion
65,044

 
28,935

Non-current deferred revenue
$
21,968

 
$
8,156

Schedule of Deferred Distributors Revenue
The following table summarizes deferred distributors revenue, net of cost of sales to distributors at September 30, 2014 and June 30, 2014, respectively (in thousands):
 
September 30, 2014
 
June 30, 2014
Deferred distributors revenue
$
34,206

 
$
40,715

Deferred cost of sales to distributors
(8,146
)
 
(8,723
)
Deferred distributors revenue, net of cost of sales to distributors
$
26,060

 
$
31,992

Schedule of Debt
The Company's debt is comprised of the following:
 
 
September 30, 2014
Current portion of long-term debt:
 
 
Term Loan
 
6,500

Revolving Facility
 
24,000

Current portion of long-term debt
 
30,500

 
 
 
Long-term debt, less current portion:
 
 
Term Loan
 
55,250

Revolving Facility
 
35,000

Total long-term debt, less current portion
 
90,250

Total debt
 
120,750

Schedule of Product Warranty Liability
The following table summarizes the activity related to the Company’s product warranty liability during the three months ended September 30, 2014 and 2013:
 
 
Three Months Ended
 
September 30, 2014
 
September 30, 2013
Balance beginning of period
$
7,551

 
$
3,296

New warranties issued
2,265

 
1,304

Warranty expenditures
(1,927
)
 
(1,160
)
Balance end of period
$
7,889

 
$
3,440

Schedules of Concentration of Risk, by Risk Factor
The following table sets forth major customers accounting for 10% or more of our net revenue:
 
 
Three Months Ended
 
 
September 30, 2014
 
September 30, 2013
Tech Data
 
14%
 
*
Westcon Group Inc.
 
13%
 
18%
Scansource, Inc.
 
*
 
14%
 
 
 
 
 
* Less than 10% of revenue